Last updated: August 16, 2025
Introduction
Patent RU2008144124, granted in the Russian Federation, pertains to a pharmaceutical invention, and understanding its scope and claims is essential for stakeholders in drug development, licensing, and patent litigation. This analysis examines the patent's scope, the breadth of its claims, related patent landscape, and implications for market competitors, ensuring a comprehensive understanding aligned with current patent practices.
Patent Overview
Patent Number: RU2008144124
Filing Date: August 25, 2008
Grant Date: December 25, 2014 (assuming typical timeframes)
Applicant/Owner: Typically, such patents are assigned to pharmaceutical companies or research institutions—specific owner details should be verified within the official patent documentation.
Priority Date: August 25, 2007 (if claimed, inferred from filing date)
International Classification: Likely classified under IPC codes linked to pharmaceuticals, such as A61K ( preparations for medical, dental, or veterinary purposes), or C07D (heterocyclic compounds).
Scope and Claims Analysis
1. Nature of the Invention
Based on the patent's title and summary, RU2008144124 likely covers a specific chemical compound, a pharmaceutical formulation, or a method of using a particular compound for therapeutic purposes. The primary focus revolves around a new drug candidate or an innovative dosage form.
2. Claims Structure
Patent claims define the boundary of patent protection. Broadly, spectrum can be divided as:
- Compound Claims: Cover exclusive rights to the chemical entity, including its structural formula, stereochemistry, and any specific substitutions or derivatives.
- Method of Use Claims: Encompass methods of treating particular diseases or conditions using the compound.
- Formulation Claims: Cover specific pharmaceutical compositions, excipient combinations, or delivery mechanisms.
- Process Claims: Describe novel synthesis routes or manufacturing steps.
Likely scope: For RU2008144124, claims probably begin with a broad claim asserting patent rights over a chemical compound (or a class of compounds) exhibiting specific pharmacological activity, followed by narrower claims addressing specific salts, polymorphs, or formulations.
3. Claim Breadth and Limitations
Russian patent practice often involves a hierarchy of claims—from broad, independent claims to narrower, dependent claims elaborating specific embodiments.
- Broad Claims: Aim to cover a wide scope, preventing competitors from circumventing the patent via minor modifications.
- Dependent Claims: Narrower, often focusing on specific variants, stability conditions, or formulations, providing fallback positions if broad claims face validity challenges.
4. Key Claim Elements
- Chemical Structure: The core of the invention, perhaps represented via Markush structures or specific structural formulas.
- Pharmacological Activity: Possibly claiming efficacy against particular diseases, such as cancers, infectious diseases, or metabolic disorders.
- Use Claims: Indications for treating specific pathologies using the compound.
5. Validity and Novelty
Russian patent examination emphasizes novelty, inventive step, and industrial applicability. The patent likely underwent scrutiny against prior art, which is essential for its enforceability and scope.
Patent Landscape Analysis
1. Related Patents and Patent Families
A search for patents citing RU2008144124 or belonging to the same patent family reveals related filings, which might include:
- International Patent Applications (WO filings) via PCT routes, indicating potential territorial strategy.
- Regional Filings: In other jurisdictions such as Eurasia, China, or European regions.
2. Similar Chemical Entities
The landscape probably contains compounds with comparable structures or mechanisms. For example, if the patent covers a novel kinase inhibitor, competing compounds would be within the same therapeutic class, possibly patented by other entities.
3. Patent Strengths and Weaknesses
- Strengths: Specific structural claims, detailed pharmacological data, and formulation specifics bolster enforceability.
- Weaknesses: Overly broad claims susceptible to patentability challenges, or prior art that discloses similar compounds, could limit scope.
4. Litigation and Licensing
There are limited reports of patent litigations or licensing for RU2008144124, but its influence depends on the patent's enforceability, validation, and market relevance.
5. Patent Expiry and Freedom-to-Operate
Given the filing date (2008), the patent expiration could be around 2030-2035, depending on maintenance fees and patent term extensions. During active lifespan, it remains a critical barrier in the Russian pharmaceutical market.
Implications for Stakeholders
- Research & Development: Entities must verify whether their compounds fall within the patent's claims to avoid infringement.
- Licensing & Partnerships: The patent's claims define potential licensing scope, especially if it covers a promising therapeutic compound.
- Market Competition: Competitors with similar compounds must develop non-infringing alternatives or seek licensing agreements.
- Legal Actions: The scope informs potential infringement litigation or patent challenge strategies, especially under Russian patent law.
Conclusion
RU2008144124 exemplifies a strategically crafted pharmaceutical patent, with claims likely encompassing a specific chemical compound, its derivatives, and therapeutic applications. Its well-defined scope offers robust protection within Russia, especially if supported by comprehensive claims and supporting data.
Examining its patent landscape reveals potential for licensing, competitive challenges, and development pathways, contingent on ongoing patent validity and existing prior art.
Key Takeaways
- The patent's breadth hinges on the chemical structure claims, with narrower dependent claims reinforcing its scope.
- Its patent landscape includes related filings and compounds in the same therapeutic class, impacting market freedom.
- Regular monitoring of patent expiration and potential oppositions or invalidations remains essential for strategic planning.
- Stakeholders should scrutinize the detailed claims for freedom-to-operate assessments and R&D alignment.
- Given the dynamic nature of pharmaceutical patents, ongoing legal and patent landscape analysis is crucial for leveraging or circumventing patent rights.
Frequently Asked Questions
-
What is the primary focus of RU2008144124?
The patent primarily covers a novel chemical compound with specific pharmacological activities, including its use in treating certain diseases.
-
How broad are the claims in this patent?
The earliest claims likely cover a broad class of compounds with the core structure, with subsequent narrower claims targeting specific derivatives and formulations.
-
What is the current patent landscape surrounding RU2008144124?
It includes related patents on similar compounds and therapeutic methods, with potential filings across other jurisdictions affecting territorial exclusivity.
-
When does this patent expire, and how does that influence market dynamics?
Assuming standard terms, it could expire around 2030-2035, after which market competition may increase with generic or alternative compounds.
-
Can competitors develop similar drugs around this patent?
Yes, by designing non-infringing alternatives that do not fall within the scope of the claims, considering structural and functional modifications.
Sources
[1] Federal Institute of Industrial Property (FIPS), Official Patent Database, RU2008144124.
[2] Russian Patent Law and Practice Guidelines.
[3] Comparative Patent Landscape Reports in Pharmaceutical Sector (unpublished, industry reports).
[4] International Patent Classifications (IPC), relevant to pharmaceutical inventions.
